1,668 results on '"Mall, Marcus"'
Search Results
2. Mukoviszidose im Kindes- und im Erwachsenenalter
3. Zukunft der Mukoviszidoseforschung und -therapie
4. Cystic fibrosis
5. Immune-mediated inflammatory diseases (IMIDs) in children: key research questions and some answers
6. Ion mobility-tandem mass spectrometry of mucin-type O-glycans
7. A novel thiol-saccharide mucolytic for the treatment of muco-obstructive lung diseases
8. Ileal mucus viscoelastic properties differ in Crohn’s disease
9. Lymphocyte transformation tests predict delayed-type allergy to piperacillin/tazobactam in patients with cystic fibrosis
10. Generalized anxiety disorder in Berlin school children after the third COVID-19 wave in Germany: a cohort study between June and September 2021
11. Elexacaftor/tezacaftor/ivacaftor improves chronic rhinosinusitis detected by magnetic resonance imaging in children with cystic fibrosis on long-term therapy with lumacaftor/ivacaftor
12. Nasal lavage microbiome, but not nasal swab microbiome, correlates with sinonasal inflammation in children with cystic fibrosis
13. Characterization of transient and progressive pulmonary fibrosis by spatially correlated phase contrast microCT, classical histopathology and atomic force microscopy
14. Potential systemic effects of acquired CFTR dysfunction in COPD
15. Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective
16. The future of cystic fibrosis treatment: from disease mechanisms to novel therapeutic approaches
17. Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials
18. Mukoviszidose
19. Incidence and outcomes of SARS-CoV-2-associated PIMS in Germany: a nationwide analysis
20. Depression Symptoms in Patients with Cystic Fibrosis Fluctuate at Baseline and Improve with Elexacaftor/Tezacaftor/Ivacaftor Therapy
21. Contrast agent-free functional magnetic resonance imaging with matrix pencil decomposition to quantify abnormalities in lung perfusion and ventilation in patients with cystic fibrosis
22. Comprehensive Characterization of the Viscoelastic Properties of Bovine Submaxillary Mucin (BSM) Hydrogels and the Effect of Additives
23. Health-related quality of life and impact of socioeconomic status among primary and secondary school students after the third COVID-19 wave in Berlin, Germany
24. Cystic fibrosis in childhood and adulthood
25. Macrophage PD-1 associates with neutrophilia and reduced bacterial killing in early cystic fibrosis airway disease
26. Magnetic resonance imaging detects improvements of pulmonary and paranasal sinus abnormalities in response to elexacaftor/tezacaftor/ivacaftor therapy in adults with cystic fibrosis
27. Comparison of the Lung Clearance Index in Preschool Children With Primary Ciliary Dyskinesia and Cystic Fibrosis
28. DMBT1 is upregulated in cystic fibrosis, affects ciliary motility, and is reduced by acetylcysteine
29. ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19
30. Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial
31. Thiolated polyglycerol sulfate as potential mucolytic for muco-obstructive lung diseases.
32. Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells
33. SARS-CoV-2 Seroprevalence in a Berlin Kindergarten Environment: A Cross-Sectional Study, September 2021
34. Reflection confocal microscopy for quantitative assessment of airway surface liquid dysregulation and pharmacological rescue in cystic fibrosis under near-physiological conditions
35. Thiolated polyglycerol sulfate as potential mucolytic for muco-obstructive lung diseases
36. Elexacaftor/tezacaftor/ivacaftor improves nasal nitric oxide in patients with cystic fibrosis
37. Therapeutic improvement of CFTR function and reversibility of bronchiectasis in cystic fibrosis
38. Multiple-breath washout to detect lung disease in patients with inborn errors of immunity
39. Pharmacological Improvement of CFTR Function Rescues Airway Epithelial Homeostasis and Host Defense in Children with Cystic Fibrosis
40. A comprehensive characterization of the viscoelastic properties of Bovine Submaxillary Mucin (BSM) and the effect of additives
41. Ileal mucus viscoelastic properties differ in Crohns disease
42. Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosis
43. Self-collected oral, nasal and saliva samples yield sensitivity comparable to professionally collected oro-nasopharyngeal swabs in SARS-CoV-2 diagnosis among symptomatic outpatients
44. COVID-19 in Pediatric Populations
45. Pharmacological Improvement of Cystic Fibrosis Transmembrane Conductance Regulator Function Rescues Airway Epithelial Homeostasis and Host Defense in Children with Cystic Fibrosis.
46. CCR3-dependent eosinophil recruitment is regulated by sialyltransferase ST3Gal-IV.
47. The future of cystic fibrosis care: a global perspective
48. Lymphocyte transformation tests predict delayed-type allergy to piperacillin/tazobactam in patients with cystic fibrosis
49. Ion Mobility-Tandem Mass Spectrometry of Mucin-type O-Glycans
50. Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in People With Cystic Fibrosis and at Least OneF508delAllele: 144-Week Interim Results From a 192-Week Open-label Extension Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.